Department of Emergency Medicine, Mayo Clinic, Rochester, Minn.
Division of Allergic Diseases, Mayo Clinic, Rochester, Minn.
J Allergy Clin Immunol Pract. 2016 Nov-Dec;4(6):1220-1226. doi: 10.1016/j.jaip.2016.06.003. Epub 2016 Jul 9.
Anaphylaxis diagnostic criteria were proposed at the Second Symposium on the Definition and Management of Anaphylaxis. These criteria were 97% sensitive and 82% specific when retrospectively validated.
To prospectively evaluate the diagnostic accuracy of the National Institute of Allergy and Infectious Diseases/Food Allergy and Anaphylaxis Network (NIAID/FAAN) criteria for diagnosis of anaphylaxis in the emergency department (ED).
We conducted a prospective observational study of patients seen in our institution's ED from April 2010 to March 2013. Patients seeking care for an allergic reaction and possible anaphylaxis were enrolled. Patients and providers completed questionnaires regarding onset, trigger, and signs and symptoms. Records were reviewed independently and blindly by 2 board-certified allergist-immunologists, and their final diagnosis (anaphylaxis vs no anaphylaxis) was used as the reference standard. Two-by-two tables were built, and test characteristics were calculated.
Among the 174 enrolled patients, 91 (52%) met the NIAID/FAAN criteria for anaphylaxis. The allergist-immunologists diagnosed 61 cases of anaphylaxis (35%), of which 58 (95%) also satisfied the NIAID/FAAN criteria. The interrater agreement between allergist-immunologists was substantial (κ = 0.7). Test characteristics (95% CIs) of the NIAID/FAAN criteria were as follows: sensitivity, 95.1% (85.4%-98.7%); specificity, 70.8% (61.4%-78.8%); positive predictive value, 63.7% (52.9%-73.4%); negative predictive value, 96.4% (89.1%-99.1%); positive likelihood ratio, 3.26; and negative likelihood ratio, 0.07.
Prospectively, the NIAID/FAAN criteria continued to be highly sensitive (95%) but had lower specificity (71%) than on retrospective assessment. These criteria are likely to be useful for the diagnosis of anaphylaxis in the ED.
过敏反应诊断标准是在第二届过敏反应定义和管理研讨会上提出的。这些标准在回顾性验证时的敏感性为 97%,特异性为 82%。
前瞻性评估国立过敏和传染病研究所/食物过敏和过敏反应网络(NIAID/FAAN)标准在急诊科(ED)诊断过敏反应的诊断准确性。
我们对 2010 年 4 月至 2013 年 3 月在我们机构 ED 就诊的患者进行了前瞻性观察性研究。招募了因过敏反应和可能过敏反应寻求治疗的患者。患者和医务人员就发病、诱因以及体征和症状填写了问卷。记录由 2 位经过董事会认证的过敏免疫学家独立和盲法进行审查,他们的最终诊断(过敏反应与无过敏反应)被用作参考标准。建立了 2×2 表,并计算了测试特征。
在 174 名入组患者中,91 名(52%)符合 NIAID/FAAN 过敏反应标准。过敏免疫学家诊断了 61 例过敏反应(35%),其中 58 例(95%)也符合 NIAID/FAAN 标准。过敏免疫学家之间的观察者间一致性很高(κ=0.7)。NIAID/FAAN 标准的测试特征(95%CI)如下:敏感性为 95.1%(85.4%-98.7%);特异性为 70.8%(61.4%-78.8%);阳性预测值为 63.7%(52.9%-73.4%);阴性预测值为 96.4%(89.1%-99.1%);阳性似然比为 3.26;阴性似然比为 0.07。
前瞻性地,NIAID/FAAN 标准的敏感性(95%)仍然很高,但特异性(71%)低于回顾性评估。这些标准可能对 ED 中过敏反应的诊断有用。